Jérôme Torrisani

2.1k total citations
40 papers, 1.5k citations indexed

About

Jérôme Torrisani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jérôme Torrisani has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Jérôme Torrisani's work include Pancreatic and Hepatic Oncology Research (14 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (8 papers). Jérôme Torrisani is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (8 papers). Jérôme Torrisani collaborates with scholars based in France, Canada and Sweden. Jérôme Torrisani's co-authors include Pierre Cordelier, Louis Buscail, Yannick Delpu, Barbara Bournet, Naı̈ma Hanoun, Yong‐Yeon Cho, Flavie Sicard, Alexander Unterberger, Moshe Szyf and Cristina Barboza‐Solís and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Jérôme Torrisani

40 papers receiving 1.5k citations

Peers

Jérôme Torrisani

ONCOL

GENET

EPIDE

Minoru Isomura Japan

Luis G. Carvajal‐Carmona United States

Geraldine Thomas United Kingdom

Koen De Geest United States

Stéphanie Langlois Canada

Christopher B. Miller United States

Giovanni Neri Italy

Alison L. Young Australia

Allen L. Horwitz United States

Thomas Buekers United States

Minoru Isomura Japan

Jérôme Torrisani

831 ×0.8

196 ×0.4

207 ×0.5

ONCOL

242 ×1.6

GENET

81 ×0.6

EPIDE

Citations per year, relative to Jérôme Torrisani Jérôme Torrisani (= 1×) peers Minoru Isomura

Countries citing papers authored by Jérôme Torrisani

Since Specialization

Citations

This map shows the geographic impact of Jérôme Torrisani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Torrisani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Torrisani more than expected).

Fields of papers citing papers by Jérôme Torrisani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Torrisani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Torrisani. The network helps show where Jérôme Torrisani may publish in the future.

Co-authorship network of co-authors of Jérôme Torrisani

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Torrisani. A scholar is included among the top collaborators of Jérôme Torrisani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Torrisani. Jérôme Torrisani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Béry, Nicolas, Marion Gayral, Lucille Stuani, et al.. (2024). Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. Communications Biology. 7(1). 1065–1065. 6 indexed citations

Souidi, Mouloud, Bélinda Duchêne, Bernadette Neve, et al.. (2021). Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma. Cancers. 13(24). 6197–6197. 7 indexed citations

Hanoun, Naı̈ma, Lætitia Ligat, Hubert Lulka, et al.. (2020). The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability. Scientific Reports. 10(1). 789–789. 23 indexed citations

Junien, Claudine, Polina Panchenko, Luciano Pirola, et al.. (2016). Épigénétique et réponses transgénérationnelles aux impacts de l’environnement. médecine/sciences. 32(1). 35–44. 10 indexed citations

Delpu, Yannick, Florence Renaud, Emmanuelle Leteurtre, et al.. (2015). Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(10). 2392–2403. 97 indexed citations

Buscail, Louis, Barbara Bournet, Marlène Dufresne, Jérôme Torrisani, & Pierre Cordelier. (2015). Nouveautés dans la biologie du cancer du pancréas. Bulletin du Cancer. 102(6). S53–S61. 6 indexed citations

Sicard, Flavie, Frédéric Martins, Barbara Bournet, et al.. (2015). Salivary MicroRNA in Pancreatic Cancer Patients. PLoS ONE. 10(6). e0130996–e0130996. 98 indexed citations

Delpu, Yannick, Audrey Vincent, Florence Renaud, et al.. (2014). miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer. Oncogene. 34(6). 780–788. 57 indexed citations

Hanoun, Naı̈ma, Odile Gayet, Véronique Gigoux, et al.. (2014). The E3 Ubiquitin Ligase Thyroid Hormone Receptor-interacting Protein 12 Targets Pancreas Transcription Factor 1a for Proteasomal Degradation. Journal of Biological Chemistry. 289(51). 35593–35604. 16 indexed citations

10.

Delpu, Yannick, Hubert Lulka, Flavie Sicard, et al.. (2013). The Rescue of miR-148a Expression in Pancreatic Cancer: An Inappropriate Therapeutic Tool. PLoS ONE. 8(1). e55513–e55513. 22 indexed citations

11.

Bournet, Barbara, Marlène Dufresne, Janick Sèlves, et al.. (2013). OncogèneKraset cancer du pancréas. médecine/sciences. 29(11). 991–997. 9 indexed citations

12.

Torrisani, Jérôme, et al.. (2013). miRNA in clinical practice: Pancreatic cancer. Clinical Biochemistry. 46(10-11). 933–936. 28 indexed citations

13.

Kar, Swayamsiddha, Moonmoon Deb, Dipta Sengupta, et al.. (2012). An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function. Epigenetics. 7(9). 994–1007. 82 indexed citations

14.

Delpu, Yannick, Naı̈ma Hanoun, Hubert Lulka, et al.. (2011). Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis. Current Genomics. 12(1). 15–24. 95 indexed citations

15.

Hanoun, Naı̈ma, Christophe Bureau, Odile Gayet, et al.. (2010). The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions. Journal of Hepatology. 53(5). 880–888. 30 indexed citations

16.

Bureau, Christophe, Naı̈ma Hanoun, Jérôme Torrisani, et al.. (2009). Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis. Current Genomics. 10(5). 353–360. 67 indexed citations

17.

Torrisani, Jérôme, et al.. (2008). DNA Demethylase transforms normal cells into highly invasive and metastatic cancer cells: Identification and characterization of novel metastatic cancer targets, therapeutic intervention for these targets, and signaling pathways leading to DNA demethylation. Cancer Research. 68. 13–13. 2 indexed citations

18.

Buscail, Louis, Fabienne Vernejoul, Patrice Faure, Jérôme Torrisani, & Christiane Susini. (2008). Contrôle de la prolifération cellulaire par la somatostatine. Annales d Endocrinologie. 63(2). 1 indexed citations

19.

Bureau, Christophe, M. Bouisson, Marie Danjoux, et al.. (2007). Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 23(1). 78–86. 18 indexed citations

20.

Saint‐Laurent, Nathalie, Jérôme Torrisani, Andrew V. Schally, et al.. (2001). Transcriptional Activation of Mouse sst2 Somatostatin Receptor Promoter by Transforming Growth Factor-β. Journal of Biological Chemistry. 276(16). 13461–13468. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact